Illumina Inc., a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), has announced the five founding members of the Alliance for Genomic Discovery (AGD). The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical genomic resource...
Tecan proudly unveils Phase Separator™, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders. Phase Separator is a unique pipetting capability of the new Air Flexible Channel Arm™ (Air FCA) on Tecan’s flagship liquid handling platform, the Fluent® Automation Workstation..
Award-winning analytical instrument manufacturer Markes International has announced that it has entered into an agreement with ExtraTECH Analytical Solutions to globally sell ExtraTECH’s newly developed and patented vacuum-assisted caps for headspace microextraction. The caps ingeniously extend the applicability of headspace, SPME and SPME Arrow sample extractions by allowing analytes to be extracted under vacuum conditions with milder heating and agitation than is required using current non-vacuum methods....
Despite recommendations from the European Society for Medical Oncology and the EU Beating Cancer Plan, uptake of next-generation sequencing (NGS) in lung cancer remains slow and inequitable across Europe. In the first report of its kind, experts highlight action needed to correct disparity in access to a gold-standard diagnostic technology that could benefit tens of thousands of lung cancer patients across Europe every year...
Eremid® Genomic Services, LLC (“Eremid”), a leading-edge genomics CRO, has announced that it has secured an additional $3.0M investment from venture capital firm Coddle Creek Capital (“CCC”) following its acquisition in 2022. CCC’s Fund 2 will support Eremid's continued growth and the expansion of its clinical genomics capabilities, reinforcing its position as a high-end, scientifically-driven genomics partner in the growing biotech hub at the North Carolina Research Campus, Kannapolis, NC...
Biotech Fluidics AB reports that it is supplying key microfluidic and degassing components to BioNavis Oy (Tampere, Finland) for its range of Multi-Parametric Surface Plasmon Resonance (MP-SPR) instruments. Surface Plasmon Resonance is the ‘go to’ technique for the measurement of molecular interactions in fluidics including serum, saliva, and organic solvents. SPR technology beneficially allows evaluation of affinity and kinetics of molecular binding reactions without the burdens of labelling as the technique is label-free...
Recycling and industrial biotechnology innovator, Recircle, has relocated to the North West’s sci-tech hotspot, Daresbury Science Park, with a new, tailor-made workspace combining a trifecta of laboratory spaces with modern offices. Recircle's work is dedicated to keeping valuable rubber materials within the resource stream by transforming end-of-life rubber waste into premium quality and high-performing compounds...
Streamlined small molecule microarray services to meet growing demand for novel hit-identification methodologies. Arrayjet, a leading provider of inkjet liquid-handling solutions, has announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services...
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has announced Biosyntia, a biotechnology company focused on synthetic biology and metabolic engineering, has adopted the Pico-Mine®platform within its workflows. The platform was chosen by Biosyntia to harness its ultra-high-throughput, picodroplet-based screening capabilities, to accelerate development of novel industrially-relevant cell factories and advance bio-based production of nutritional ingredients...
Scientific Laboratory Supplies Ltd (SLS) has launched its latest Back2Basics magazine, featuring exclusive offers on essentials for your laboratory. The 2023 issue is now live, and SLS is working closely with a number of key suppliers to bring you the best deals in the market for selected laboratory products. In this issue, SLS has fantastic offers on selected lines from their own SLS Lab Pro, SLS Select and SLS Lab Basics brands alongside those from world-renowned manufacturers such as Eppendorf, IKA, Ohaus, Corning, Gilson, Thermo Scientific and many more...
The growth of U.S. life sciences researchers remains resilient in the face of economic concerns, according to a recent analysis conducted by CBRE. The number of life sciences researchers in the U.S. increased by 87% over the past 20 years, compared with 14% for all U.S. occupations. Research jobs have not fallen across those 20 years, through three recessions and amid a tight labor market of recent years...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, has inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory. The hub is a one-stop facility serving the needs of customers across Asia, Middle East, and Africa (AMEA), strengthening the region's innovation and biopharma ecosystems...
Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. Discovery Spark is currently accepting applications from life-science start-ups, with a closing deadline of 20 August. From the first cohort of up to 12 companies, one business will be selected to win a prize package worth over £100,000, including £50,000 investment from Discovery Park Ventures, 1 year of free lab space at Discovery Park, plus wrap-around business support and dedicated mentoring...
Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future. Under an academic and commercial collaboration between The Institute of Cancer Research, London, the Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, and the company Vivan Therapeutics, a multi-disciplijnary team will seek to create drugs that can counteract drug resistance...
NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program. The funding will support preclinical development, including development of a manufacturing process in collaboration with the Cell and Gene Therapy Catapult, whose mission is to support the UK’s cell and gene therapy industry...
Merck, has awarded Khalid Salaita, Samuel Candler Dobbs Professor in the Department of Chemistry at Emory University, Atlanta, Georgia, U.S.A., with the Future Insight Prize 2023 worth € 500,000 for research on a pandemic early alert system. Salaita’s group is developing a novel platform technology for automated surveillance and tracing of airborne pathogens in real time...
Uniqsis report major growth in sales of its FlowSyn, FlowLab and modular based flow chemistry reactor systems to leading Chinese academic institutions. Most recently, local distributor - Beijing SMS has installed systems at ICCAS, Kunming University and Sichuan University. These academic institutions were interested in acquiring easy to use and maintain, high performance flow chemistry systems...
Automata, a leading automation company powering life sciences labs, announces its partnership with The Royal Marsden NHS Foundation Trust to unlock the power of open, integrated automation for cancer sample testing. With Automata’s support, the hospital’s Clinical Genomics Service, which is the cancer testing laboratory for the North Thames Genomics Laboratory Hub (NTGLH), will double its genomic testing capacity through a new robotic sample processing platform...
The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies. These products have streamlined the center’s sample transfer protocols, leading to shorter turnaround times and supporting vital research into the prevention and control of viral respiratory diseases. The CEVT was established in March 2020 to address the urgent testing needs caused by the COVID-19 pandemic...
Technological market leader in ultra-high-speed imaging - Specialised Imaging Ltd. will celebrate 20 years in business during July 2023. In 2003, Specialised Imaging Ltd. embarked on a journey to bring new innovations to ultra-high-speed imaging instruments and to create systems that are more intuitive to the user and offer a world class level of reliability and support...
VitaDAO, the global community accelerating research and development in longevity science, is pleased to announce the launch of the VITA-FAST tokens. This marks the first-ever opportunity for token holders to directly influence longevity research, setting a new precedent in the field of decentralized science (DeSci). The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met with overwhelming interest...
The European Molecular Biology Laboratory (EMBL) and ZEISS have entered a long-term strategic partnership. The collaboration aims to close the gap between early-stage imaging technology development and its application in life science research. Through this collaborative approach, users of the EMBL Imaging Centre and related EMBL imaging services will have access to the latest microscopy technologies and expertise from ZEISS...
Illumina Inc., a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), has announced the five founding members of the Alliance for Genomic Discovery (AGD). The multiyear agreement aims to accelerate development of therapeutics through large-scale genomics and the establishment of a preeminent clinical genomic resource...
Tecan proudly unveils Phase Separator™, an innovative liquid separation technology that promises to save time and improve accuracy in laboratory workflows. With specific applications in liquid biopsy and biobanking, its benefits will be felt in genomics, proteomics and across multiple disease areas, from oncology and neurodegenerative disease to metabolic disorders. Phase Separator is a unique pipetting capability of the new Air Flexible Channel Arm™ (Air FCA) on Tecan’s flagship liquid handling platform, the Fluent® Automation Workstation..
Award-winning analytical instrument manufacturer Markes International has announced that it has entered into an agreement with ExtraTECH Analytical Solutions to globally sell ExtraTECH’s newly developed and patented vacuum-assisted caps for headspace microextraction. The caps ingeniously extend the applicability of headspace, SPME and SPME Arrow sample extractions by allowing analytes to be extracted under vacuum conditions with milder heating and agitation than is required using current non-vacuum methods....
Despite recommendations from the European Society for Medical Oncology and the EU Beating Cancer Plan, uptake of next-generation sequencing (NGS) in lung cancer remains slow and inequitable across Europe. In the first report of its kind, experts highlight action needed to correct disparity in access to a gold-standard diagnostic technology that could benefit tens of thousands of lung cancer patients across Europe every year...
Eremid® Genomic Services, LLC (“Eremid”), a leading-edge genomics CRO, has announced that it has secured an additional $3.0M investment from venture capital firm Coddle Creek Capital (“CCC”) following its acquisition in 2022. CCC’s Fund 2 will support Eremid's continued growth and the expansion of its clinical genomics capabilities, reinforcing its position as a high-end, scientifically-driven genomics partner in the growing biotech hub at the North Carolina Research Campus, Kannapolis, NC...
Biotech Fluidics AB reports that it is supplying key microfluidic and degassing components to BioNavis Oy (Tampere, Finland) for its range of Multi-Parametric Surface Plasmon Resonance (MP-SPR) instruments. Surface Plasmon Resonance is the ‘go to’ technique for the measurement of molecular interactions in fluidics including serum, saliva, and organic solvents. SPR technology beneficially allows evaluation of affinity and kinetics of molecular binding reactions without the burdens of labelling as the technique is label-free...
Recycling and industrial biotechnology innovator, Recircle, has relocated to the North West’s sci-tech hotspot, Daresbury Science Park, with a new, tailor-made workspace combining a trifecta of laboratory spaces with modern offices. Recircle's work is dedicated to keeping valuable rubber materials within the resource stream by transforming end-of-life rubber waste into premium quality and high-performing compounds...
Streamlined small molecule microarray services to meet growing demand for novel hit-identification methodologies. Arrayjet, a leading provider of inkjet liquid-handling solutions, has announced that it has partnered with Chemspace, the largest online catalogue of small molecules and biologics, to augment and streamline the Company’s small molecule microarray (SMM) service offering. Chemspace’s curated and deeply annotated compound libraries are now accessible through Arrayjet’s SMM CRO/CMO services...
Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, has announced Biosyntia, a biotechnology company focused on synthetic biology and metabolic engineering, has adopted the Pico-Mine®platform within its workflows. The platform was chosen by Biosyntia to harness its ultra-high-throughput, picodroplet-based screening capabilities, to accelerate development of novel industrially-relevant cell factories and advance bio-based production of nutritional ingredients...
Scientific Laboratory Supplies Ltd (SLS) has launched its latest Back2Basics magazine, featuring exclusive offers on essentials for your laboratory. The 2023 issue is now live, and SLS is working closely with a number of key suppliers to bring you the best deals in the market for selected laboratory products. In this issue, SLS has fantastic offers on selected lines from their own SLS Lab Pro, SLS Select and SLS Lab Basics brands alongside those from world-renowned manufacturers such as Eppendorf, IKA, Ohaus, Corning, Gilson, Thermo Scientific and many more...
The growth of U.S. life sciences researchers remains resilient in the face of economic concerns, according to a recent analysis conducted by CBRE. The number of life sciences researchers in the U.S. increased by 87% over the past 20 years, compared with 14% for all U.S. occupations. Research jobs have not fallen across those 20 years, through three recessions and amid a tight labor market of recent years...
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies, and applied materials industries, has inaugurated its expanded Singapore Hub which includes newly added cGMP manufacturing and a world class quality control laboratory. The hub is a one-stop facility serving the needs of customers across Asia, Middle East, and Africa (AMEA), strengthening the region's innovation and biopharma ecosystems...
Discovery Park, in Sandwich, Kent has launched a new business support programme and competition, ‘Discovery Spark’. Discovery Spark is currently accepting applications from life-science start-ups, with a closing deadline of 20 August. From the first cohort of up to 12 companies, one business will be selected to win a prize package worth over £100,000, including £50,000 investment from Discovery Park Ventures, 1 year of free lab space at Discovery Park, plus wrap-around business support and dedicated mentoring...
Researchers are set to to combine expertise in drug discovery, artificial intelligence (AI), and experimental cancer models and platforms in a new programme to design the precision cancer drugs of the future. Under an academic and commercial collaboration between The Institute of Cancer Research, London, the Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, and the company Vivan Therapeutics, a multi-disciplijnary team will seek to create drugs that can counteract drug resistance...
NK:IO, a leader in NK cell biology applied to the development of exceptionally potent, off-the-shelf cell therapies targeting solid tumours, has announced it has been awarded £1.6M in grant funding from Innovate UK’s New Cancer Therapeutics program. The funding will support preclinical development, including development of a manufacturing process in collaboration with the Cell and Gene Therapy Catapult, whose mission is to support the UK’s cell and gene therapy industry...
Merck, has awarded Khalid Salaita, Samuel Candler Dobbs Professor in the Department of Chemistry at Emory University, Atlanta, Georgia, U.S.A., with the Future Insight Prize 2023 worth € 500,000 for research on a pandemic early alert system. Salaita’s group is developing a novel platform technology for automated surveillance and tracing of airborne pathogens in real time...
Uniqsis report major growth in sales of its FlowSyn, FlowLab and modular based flow chemistry reactor systems to leading Chinese academic institutions. Most recently, local distributor - Beijing SMS has installed systems at ICCAS, Kunming University and Sichuan University. These academic institutions were interested in acquiring easy to use and maintain, high performance flow chemistry systems...
Automata, a leading automation company powering life sciences labs, announces its partnership with The Royal Marsden NHS Foundation Trust to unlock the power of open, integrated automation for cancer sample testing. With Automata’s support, the hospital’s Clinical Genomics Service, which is the cancer testing laboratory for the North Thames Genomics Laboratory Hub (NTGLH), will double its genomic testing capacity through a new robotic sample processing platform...
The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies. These products have streamlined the center’s sample transfer protocols, leading to shorter turnaround times and supporting vital research into the prevention and control of viral respiratory diseases. The CEVT was established in March 2020 to address the urgent testing needs caused by the COVID-19 pandemic...
Technological market leader in ultra-high-speed imaging - Specialised Imaging Ltd. will celebrate 20 years in business during July 2023. In 2003, Specialised Imaging Ltd. embarked on a journey to bring new innovations to ultra-high-speed imaging instruments and to create systems that are more intuitive to the user and offer a world class level of reliability and support...
VitaDAO, the global community accelerating research and development in longevity science, is pleased to announce the launch of the VITA-FAST tokens. This marks the first-ever opportunity for token holders to directly influence longevity research, setting a new precedent in the field of decentralized science (DeSci). The VITA-FAST tokens, which allow holders to make decisions on IP licensing, set experiment priorities, and govern research on autophagy, have been met with overwhelming interest...
The European Molecular Biology Laboratory (EMBL) and ZEISS have entered a long-term strategic partnership. The collaboration aims to close the gap between early-stage imaging technology development and its application in life science research. Through this collaborative approach, users of the EMBL Imaging Centre and related EMBL imaging services will have access to the latest microscopy technologies and expertise from ZEISS...